💨 Abstract

Concept Medical's sirolimus-coated balloons showed similar patency and functional benefits as paclitaxel-coated balloons for patients with peripheral artery disease (PAD) in the SIRONA RCT. The 1-year data, presented at TCT USA 2024, showed a primary patency rate of 73.8%

Courtesy: theprint.in

Summarized by Einstein Beta 🤖

Powered by MessengerX.io